Editorial Advisory Board

Article

EAB

Editorial Advisory Board

OTE's Editorial Advisory Board of key European opinion leaders ensures coverage of and expert opinion on all latest research findings and issues affecting the industry.

Jorge Alio, MD
Instituto Oftalmologico de Alicante, Alicante, Spain

Albert Augustin, MD
Klinikum Karlsruhe, Karlsruhe, Germany

Rafael Barraquer, MD
Institut Universitari Barraquer and Centro de Oftalmología Barraquer, Barcelona, Spain

Christophe Baudouin, MD
Quinze-Vingts National Ophthalmology Hospital, Paris, France

Johan Blanckaert, MD
Eye & Refractive Centre, Ieper, Belgium

Jean-Louis Bourges, MD
Hotel-Dieu Hospital, Paris, France

Burkhard Dick, MD
University Eye Hospital Bochum, Bochum, Germany

Christoph Faschinger, MD
Medical University of Graz, Clinic of Ophthalmology, Graz, Austria

Paolo Fazio, MD
Centro Catanese di Medicina e Chirurgia (CCHC), Catania, Italy

Alessandro Franchini, MD
University of Florence, Eye Institute - Azienda Ospedaliera Careggi, Florence, Italy

Frank Goes, MD
Goes Eye Centre Left Bank, Antwerp, Belgium

Gunther Grabner, MD
University Eye Clinic Salzburg, Salzburg, Austria

Zdenek Gregor, FRCS FRCOphth
Moorfields Eye Hospital, London, UK

Vikentia Katsanevaki, MD
Vardinogiannion Eye Institute, University of Crete, Greece

Omid Kermani, MD
PAN Klinik Koln, Cologne, Germany

Hans-Reinhard Koch, MD
Hochkreuz Augenklinik, Bonn, Germany

Pavel Kuchynka, MD
Charles University, Prague, Czech Republic

Erik L. Mertens, MD, FEBO
Antwerp Eye Center, Antwerp. Belgium

Rudy Nuijts, MD
The Academic Hospital, Maastricht, The Netherlands

Norbert Pfeiffer, MD
University of Mainz, Mainz, Germany

Roberto Pinelli, MD
Istituto Laser Microchirurgia Oculare, Brescia, Italy

Matteo Piovella, MD
C.M.A. srl Centro Microchirurgia Ambulatoriale, Monza, Italy

Imola Ratkay-Traub, MD
Danube Band Medical Centre, Hungary

Herbert A. Reitsamer, MD
Paracelsus University Salzburg, SALK University Eye Clinic, Salzburg, Austria

Theo Seiler, MD
Institut fur Refraktive & Ophthalmo-Chirurgie (IROC), and University of Zurich, Zurich, Switzerland

Berthold Seitz, MD
Universitat Erlangen-Nurnberg, Erlangen, Germany

Tarek Shaarawy, MD
University of Geneva, Geneva, Switzerland

Sunil Shah, MD
Birmingham and Midland Eye Centre, Midland Eye Institute Solihull, UK

David Spalton, MD
St Thomas' Hospital & King Edward VII's Hospital, London, UK

John Thygesen, MD
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Khiun Tjia, MD
Isala Clinics, location Weezenlanden, Zwolle, The Netherlands

Daniele Tognetto, MD
University Eye Clinic, Ospedale Maggiore, Trieste, Italy

Baha Toygar, MD
Dünya Eye Hospital, Istanbul, Turkey

Petja Vassileva, MD
National Eye Institute, Sofia, Bulgaria

Jan Venter, MD
Optimax London & Croydon Clinics, UK

Carlos Vergés, MD
Institut Universitari Dexeus, Barcelona, Spain

Paolo Vinciguerra, MD
Istituto Clinico Humanitas, Rozzano, Milan, Italy

Thierry Zeyen, MD
University Hospital, Leuven, Leuven, Belgium

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.